Sickle Cell Meeting

Katherine Wood, PhD Cytochrome b5 reductase 3 is a resilience factor in mice with sickle cell disease, modifying the brain-blood axis response to ischemic stroke

Darrell Triulzi MD The Sickle Cell Disease Cardiovascular Risk: Red Cell Exchange Trial (SCD CARRE) Maureen Mburu, MD Nonhematopoietic Nrf2 Deficiency Worsens Chronic Intravascular Hemolysis but not Cardiomyopathy in Transgenic Sickle Cell Mice

Samit Ghosh, PhD Peritubular Endothelium: an important piece of the CKD jigsaw in SCD Bethany Flage, MS The role of hemoglobin variants in Plasmodium falciparum sexual differentiation

Deirdre Nolfi-Donegan, MD
Hypercoagulability in Sickle Cell Disease: Linking Hemolysis to Thrombosis

Rimi Hazra, PhD
Vasculo-Neuronal Interactions in Sickle Cell Disease

Heidi Schmidt, PhD 
Unraveling novel roles of xanthine oxidase in Sickle Cell Disease

Atinuke “Oyin” Dosunmu-Ogunbi
A Novel Role for Endothelial Superoxide Dismutase 2 in Processing Fibronectin and Modulating Sickle Pathology

Sickle Cell Disease Research Seminar 2/28/23